MX383077B - Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio. - Google Patents
Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio.Info
- Publication number
- MX383077B MX383077B MX2016000964A MX2016000964A MX383077B MX 383077 B MX383077 B MX 383077B MX 2016000964 A MX2016000964 A MX 2016000964A MX 2016000964 A MX2016000964 A MX 2016000964A MX 383077 B MX383077 B MX 383077B
- Authority
- MX
- Mexico
- Prior art keywords
- agent
- pharmaceutical compositions
- intraocular administration
- inflammatory agent
- antibacterial agent
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- 229940121363 anti-inflammatory agent Drugs 0.000 title abstract 2
- 239000002260 anti-inflammatory agent Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 abstract 1
- 229960003702 moxifloxacin Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 abstract 1
- 229960005294 triamcinolone Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361958170P | 2013-07-22 | 2013-07-22 | |
| PCT/US2014/032026 WO2015012899A1 (en) | 2013-07-22 | 2014-03-27 | Pharmaceutical compositions for intraocular administration comprising an antibacterial agent and an antiinflammatory agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016000964A MX2016000964A (es) | 2016-08-03 |
| MX383077B true MX383077B (es) | 2025-03-13 |
Family
ID=50640013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016000964A MX383077B (es) | 2013-07-22 | 2014-03-27 | Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20150024996A1 (enExample) |
| EP (1) | EP3024475B8 (enExample) |
| JP (5) | JP2016525544A (enExample) |
| KR (1) | KR20160033213A (enExample) |
| AU (1) | AU2014293665B2 (enExample) |
| BR (1) | BR112016001544A8 (enExample) |
| CA (1) | CA2919081C (enExample) |
| IL (1) | IL243750A0 (enExample) |
| MX (1) | MX383077B (enExample) |
| WO (1) | WO2015012899A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160279055A1 (en) | 2013-07-22 | 2016-09-29 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof |
| KR20160033213A (ko) * | 2013-07-22 | 2016-03-25 | 임프리미스 파마슈티컬스 인코포레이티드 | 항균제 및 항염증제를 포함하는 안구내 투여를 위한 약학적 조성물 |
| US20150164882A1 (en) | 2013-07-22 | 2015-06-18 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| JP6682898B2 (ja) * | 2016-02-17 | 2020-04-15 | 富士通株式会社 | 基地局、無線通信システムおよび基地局の処理方法 |
| KR20190109604A (ko) * | 2016-05-06 | 2019-09-25 | 해로우 헬스 인코포레이티드 | 약학적 안과용 조성물 및 그의 제조 방법 |
| DK3541442T3 (da) | 2016-11-16 | 2022-03-14 | Persica Pharmaceuticals Ltd | Antibiotiske formuleringer mod lændesmerter |
| US11071724B2 (en) | 2019-05-17 | 2021-07-27 | Ocular Science, Inc. | Compositions and methods for treating presbyopia |
| US12102632B2 (en) | 2020-08-26 | 2024-10-01 | Somerset Therapeutics, Llc | Quinolone dispersions |
| US11484538B2 (en) | 2020-08-26 | 2022-11-01 | Somerset Therapeutics, Llc | Bromfenac, prednisolone, and moxifloxacin compositions and methods |
| US11523987B2 (en) | 2020-08-26 | 2022-12-13 | Somerset Therapeutics, Llc | Trimcinolone and moxifloxacin methods |
| US11382910B2 (en) | 2020-08-26 | 2022-07-12 | Somerset Therapeutics, Llc. | Loteprednol and moxifloxacin compositions and methods |
| EP4260844A1 (en) | 2022-04-11 | 2023-10-18 | Liegner, Jeffery T. | Ophthalmological compositions comprising poloxamer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1192368A (ja) * | 1997-07-23 | 1999-04-06 | Ono Pharmaceut Co Ltd | ベンゾピラン誘導体を主成分とする水性液剤 |
| US6378526B1 (en) * | 1998-08-03 | 2002-04-30 | Insite Vision, Incorporated | Methods of ophthalmic administration |
| JP2003176228A (ja) * | 2001-12-11 | 2003-06-24 | Rohto Pharmaceut Co Ltd | 液 剤 |
| US20070049552A1 (en) * | 2003-04-14 | 2007-03-01 | Babu Manoj M | Fluoroquinolone formulations and methods of making and using the same |
| DE602006006308D1 (de) * | 2005-05-10 | 2009-05-28 | Alcon Inc | Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten |
| US20080262415A1 (en) * | 2005-07-18 | 2008-10-23 | Peyman Gholam A | Enhanced wound healing |
| EP2962682B1 (en) * | 2008-12-11 | 2018-03-28 | Massachusetts Institute Of Technology | Method of making a contact lens drug delivery device |
| JP2013508381A (ja) * | 2009-10-21 | 2013-03-07 | オトノミ―，インク． | ポロクサマーを包含する製剤のゲル化温度の調節 |
| WO2011049958A2 (en) * | 2009-10-21 | 2011-04-28 | Otonomy, Inc. | Modulation of gel temperature of poloxamer-containing formulations |
| US20140127269A1 (en) * | 2012-02-13 | 2014-05-08 | The Schepens Eye Research Institute, Inc. | Anti-Inflammatory Peptide Derived From Thrombospondin-1 and Uses Thereof |
| KR20160033213A (ko) * | 2013-07-22 | 2016-03-25 | 임프리미스 파마슈티컬스 인코포레이티드 | 항균제 및 항염증제를 포함하는 안구내 투여를 위한 약학적 조성물 |
-
2014
- 2014-03-27 KR KR1020167004393A patent/KR20160033213A/ko not_active Ceased
- 2014-03-27 EP EP14721688.1A patent/EP3024475B8/en active Active
- 2014-03-27 AU AU2014293665A patent/AU2014293665B2/en active Active
- 2014-03-27 BR BR112016001544A patent/BR112016001544A8/pt not_active Application Discontinuation
- 2014-03-27 MX MX2016000964A patent/MX383077B/es unknown
- 2014-03-27 JP JP2016529754A patent/JP2016525544A/ja active Pending
- 2014-03-27 CA CA2919081A patent/CA2919081C/en active Active
- 2014-03-27 US US14/227,819 patent/US20150024996A1/en not_active Abandoned
- 2014-03-27 WO PCT/US2014/032026 patent/WO2015012899A1/en not_active Ceased
-
2016
- 2016-01-24 IL IL243750A patent/IL243750A0/en active IP Right Grant
-
2019
- 2019-06-11 JP JP2019108368A patent/JP7232128B2/ja active Active
-
2021
- 2021-05-18 JP JP2021083925A patent/JP2021121608A/ja active Pending
-
2022
- 2022-09-30 JP JP2022157885A patent/JP7362870B2/ja active Active
-
2023
- 2023-10-04 JP JP2023172708A patent/JP2024001149A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3024475A1 (en) | 2016-06-01 |
| JP2021121608A (ja) | 2021-08-26 |
| AU2014293665A1 (en) | 2016-02-11 |
| NZ716208A (en) | 2020-12-18 |
| HK1223824A1 (zh) | 2017-08-11 |
| JP2022185059A (ja) | 2022-12-13 |
| IL243750A0 (en) | 2016-04-21 |
| JP2019167376A (ja) | 2019-10-03 |
| MX2016000964A (es) | 2016-08-03 |
| JP7362870B2 (ja) | 2023-10-17 |
| CA2919081C (en) | 2021-11-16 |
| JP2016525544A (ja) | 2016-08-25 |
| BR112016001544A2 (pt) | 2017-07-25 |
| CA2919081A1 (en) | 2015-01-29 |
| EP3024475B1 (en) | 2020-09-30 |
| WO2015012899A1 (en) | 2015-01-29 |
| AU2014293665B2 (en) | 2017-06-01 |
| JP2024001149A (ja) | 2024-01-09 |
| BR112016001544A8 (pt) | 2021-08-03 |
| KR20160033213A (ko) | 2016-03-25 |
| EP3024475B8 (en) | 2020-11-18 |
| JP7232128B2 (ja) | 2023-03-02 |
| US20150024996A1 (en) | 2015-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX383077B (es) | Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio. | |
| CY1123937T1 (el) | Σκευασμα ξηρης σκονης που περιλαμβανει ενα αντιχολινεργικο, ενα κορτικοστεροειδες και ενα βητα-αδρενεργικο για χορηγηση δια εισπνοης | |
| BR112015018087A8 (pt) | composto, composição farmacêutica e uso | |
| ECSP15004752A (es) | Formulaciones de etanercept que muestran una marcada reducción de la cantidad de partículas subvisibles | |
| EP4592275A3 (en) | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | |
| MX2016004257A (es) | Composiciones oftalmicas basadas en epinefrina para la administracion intraocular y metodos para su frabricacion. | |
| IN2013MU03583A (enExample) | ||
| MX2016013236A (es) | Formulacion inmunosupresora. | |
| MX374944B (es) | Derivado de piranocromenil fenol, y composición farmacéutica para tratar un síndrome metabólico o enfermedad inflamatoria. | |
| CR20150637A (es) | Tratamiento de enfermedades miopaticas y neurodegenerativas por agregación de proteina mediante administración parenteral | |
| PH12019502150A1 (en) | Compounds and methods for the treatment of parasitic diseases | |
| BR112016007414A2 (pt) | método de produção de um comprimido de monocamada, e, comprimido de monocamada | |
| EP3040074A4 (en) | INJECTION PREPARATION AND METHOD FOR THE PRODUCTION THEREOF | |
| NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
| WO2015001087A3 (en) | Drug-delivery composition for topical applications and injections and ophtalmic formulations, method for manufacturing thereof, and methods for delivery a drug-delivery composition | |
| ZA201807446B (en) | Improved drug formulations | |
| NZ735777A (en) | Methods and compositions to inhibit symptoms associated with veisalgia | |
| EA201501164A1 (ru) | Твердая фармацевтическая лекарственная форма | |
| PH12017502149A1 (en) | Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester | |
| IN2013MU01985A (enExample) | ||
| TR201722603A2 (tr) | Metformi̇n ve si̇tagli̇pti̇n i̇çeren sicak eri̇tme ekstrüzyonu i̇le gerçekleşti̇ri̇len tablet formülasyonlari | |
| AR093252A1 (es) | Composicion farmaceutica oral utilizada como antiparasitaria y antidiarreica y procesos para prepararla | |
| MX381148B (es) | Polipéptidos de acción prolongada y métodos para su producción y administración. | |
| MX348595B (es) | Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion. | |
| CO2018001531A2 (es) | Lisobactina para su uso en el tratamiento de la mastitis bovina |